In his weekly clinical update Dr. Griffin discusses Mpox (formerly monkeypox) in women: epidemiological features and clinical characteristics of mpox cases in Spain, April to November 2022, triage of patients with Ebola virus disease, SARS-CoV-2 serology and self-reported infection among adults, serological markers of SARS-CoV-2 infection; anti-nucleocapsid antibody positivity may not be the ideal marker of natural infection in vaccinated individuals, sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody for breakthrough infections during the epidemic of the Omicron variants, effect of wearing glasses on risk of infection with SARS-CoV-2 in the community, and data-driven identification of post-acute SARS-CoV-2 infection subphenotypes.
Become a patron of TWiV!
Links for this episode
- Mpox in women: Epidemiological features and clinical characteristics of cases (Eurosurveillance) 4:24
- Pox in Central Africa (PBS Newshour) 5:15
- Triage of patients with Ebola virus disease (The Lancet) 7:22
- SARS-CoV-2 serology and self-reported infection among adults (CDC) 11:03
- Serological markers of SARS-CoV-2 infection (JID) 12:13
- Sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody (Journal of infection) 12:43
- Effect of wearing glasses on risk of infection with SARS-CoV-2 in the community (JAMA) 15:19
- Paxlovid patient eligbiliity screening checklist (FDA)
- Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes (Nature) 19:04
- Contribute to our MicrobeTV fundraiser at PWB 21:08
- Dr. Griffin’s treatment guide (pdf)
- Letters read on TWiV 961 21:44
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to email@example.com